Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

72.86 -1.06 (-1.43%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 23, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	5,247,369
Open	73.05
Bid (Size)	72.23 (100)
Ask (Size)	73.68 (100)
Prev. Close	73.92
Today's Range	71.66 - 73.53
52wk Range	54.11 - 93.25
Shares Outstanding	390,000,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Abbott Laboratories Shares Plunge 10% Following Q4 Revenue Miss and Diagnostics Weakness

January 22, 2026

Abbott Laboratories (NYSE: ABT) saw its stock price tumble by nearly 10% in early trading on January 22, 2026, following the release of its fourth-quarter 2025 financial results. Despite meeting...

Via MarketMinute

Abbott Shares Slump as Revenue Miss and Exact Sciences Acquisition Jitters Overshadow Earnings Beat

January 22, 2026

Abbott Laboratories (NYSE: ABT) saw its shares retreat by 5.8% in early trading on Thursday, January 22, 2026, following the release of its fourth-quarter financial results. Despite delivering an...

Via MarketMinute

Performance

YTD	+9.5%	+9.5%
1 Month	+8.1%	+8.1%
3 Month	+3.6%	+3.6%
6 Month	-18.1%	-18.1%
1 Year	-16.9%	-16.9%

More News

1 Growth Stock Down 19% to Buy Right Now ↗

January 21, 2026

Via The Motley Fool

DexCom Inc. (NASDAQ:DXCM) Combines Strong Fundamentals with Bullish Chart Pattern ↗

January 20, 2026

Via Chartmill

Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights

January 15, 2026

From Halper Sadeh LLC

Via Business Wire

Top S&P500 movers in Monday's session ↗

January 12, 2026

Via Chartmill

What's going on in today's session: S&P500 movers ↗

January 12, 2026

Via Chartmill

Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook

January 12, 2026

From DexCom, Inc.

Via Business Wire

DexCom (DXCM) Stock Trades Down, Here Is Why

January 08, 2026

Via StockStory

Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer

January 07, 2026

From DexCom, Inc.

Via Business Wire

3 Nasdaq 100 Stocks Worth Your Attention

January 04, 2026

Via StockStory

The Evolution of a Healthcare Giant: Abbott Laboratories (ABT) 2026 Stock Feature

January 01, 2026

Via PredictStreet

2 Healthcare Stocks for Long-Term Investors and 1 We Find Risky

December 31, 2025

Via StockStory

2 Growth Stocks to Buy For 2026 and Beyond ↗

December 30, 2025

Via The Motley Fool

DexCom Inc (NASDAQ:DXCM) Embodies the Growth at a Reasonable Price (GARP) Strategy ↗

December 30, 2025

Via Chartmill

DEXCOM CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds DXCM Investors of the December 26th Deadline for Contacting the Firm

December 26, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

December 26, 2025

From Schall Law

Via GlobeNewswire

The $65 Billion Pulse: How Wearable AI and Telemedicine are Redefining the Future of Healthcare

December 24, 2025

Via MarketMinute

1 Cash-Heavy Stock for Long-Term Investors and 2 We Avoid

December 22, 2025

Via StockStory

DEXCOM CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds DXCM Investors of the December 26th Deadline for Contacting the Firm

December 22, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

DXCM Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Investors of Filing Deadline in Class Action Lawsuit

December 22, 2025

Via TheNewswire.com

DXCM Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Investors of Filing Deadline in Class Action Lawsuit

December 22, 2025

Via NewMediaWire

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

December 22, 2025

From Schall Law

Via GlobeNewswire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (NASDAQ: DXCM)

December 22, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

DexCom Inc (NASDAQ:DXCM): A High-Growth Stock Forming a Bullish Technical Setup ↗

December 19, 2025

Via Chartmill

Frequently Asked Questions

Is DexCom, Inc. - Common Stock publicly traded?

Yes, DexCom, Inc. - Common Stock is publicly traded.

What exchange does DexCom, Inc. - Common Stock trade on?

DexCom, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for DexCom, Inc. - Common Stock?

The ticker symbol for DexCom, Inc. - Common Stock is DXCM on the Nasdaq Stock Market

What is the current price of DexCom, Inc. - Common Stock?

The current price of DexCom, Inc. - Common Stock is 72.86

When was DexCom, Inc. - Common Stock last traded?

The last trade of DexCom, Inc. - Common Stock was at 01/23/26 04:00 PM ET

What is the market capitalization of DexCom, Inc. - Common Stock?

The market capitalization of DexCom, Inc. - Common Stock is 28.42B

How many shares of DexCom, Inc. - Common Stock are outstanding?

DexCom, Inc. - Common Stock has 28B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.